Status:
UNKNOWN
Genetic Studies in Liver Cancer Patients
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
Industrial Technology Research Institute, Taiwan
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18-90 years
Brief Summary
Hepatocellular carcinoma (HCC) is one the most common malignancies in the world, especially in sub-Saharan Africa and Southeast Asia. Since 1984, it has been the leading cause of cancer death in Taiwa...
Detailed Description
The clinical samples will be collected in the NTUH, while the DNA microarray works will be done in Biomedical Engineering Center (BMEC) of ITRI. Patients A total of 40 cases of HCC patients (20 HBV-r...
Eligibility Criteria
Inclusion
- hepatocellular carcinoma
Exclusion
- multiple cancers
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00172640
Start Date
January 1 2005
Last Update
September 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100